grade
anhydrous
Quality Level
vapor density
>1 (vs air)
product line
ReagentPlus®, Redi-Dri™
assay
≥99%
form
powder
quality
free-flowing
impurities
≤1.0% water
pH
6-9 (20 °C, 50 g/L)
mp
661 °C (lit.)
InChI
1S/HI.Na/h1H;/q;+1/p-1
InChI key
FVAUCKIRQBBSSJ-UHFFFAOYSA-M
General description
碘化钠是一种无机钠盐。在有机合成中可用作碘化剂,制备各种含碘化合物。可用于通过亲核取代反应将卤代烃和磺酸酯转换为烷基碘化物和芳基碘化物。此外,碘化钠还可联合氧化剂碘化有机硼烷、酚和芳基化合物。
Application
碘化钠可用作碘盐前体,通过缓慢蒸发溶剂法合成双硫脲碘化钠(bis thiourea sodium iodide)的半有机非线性光学单晶。
Legal Information
ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC
Still not finding the right product?
Explore all of our products under 碘化钠
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
商品
Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.
Brian A Rabe et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(39), 24450-24458 (2020-09-10)
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had an enormous impact on society worldwide, threatening the lives and livelihoods of many. The effects will continue to grow and worsen if economies begin to open without the
P E N Braad et al.
Physics in medicine and biology, 60(13), 5297-5312 (2015-06-26)
Peri-therapeutic (124)I-PET/CT is of interest as guidance for radioiodine therapy. Unfortunately, image quality is complicated by dead time effects and increased random coincidence rates from high (131)I-activities. A series of phantom experiments with clinically relevant (124)I/(131)I-activities were performed on a
Kohei Sano et al.
Biochemical and biophysical research communications, 464(3), 820-825 (2015-07-15)
Photoacoustic (PA) imaging is an attractive imaging modality for sensitive and depth imaging of biomolecules with high resolution in vivo. The aim of this study was to evaluate the effectiveness of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (panitumumab; Pan)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 793558-500G | 04061832951362 |
| 793558-1KG | 04061832951348 |
| 793558-100G | 04061832951331 |
